Biomarkers of intrinsic angiogenic and anti-angiogenic activity in patients with endometrial hyperplasia and endometrial cancer

Acta Oncologica

Volumn 40, Issue 4, 2001, Pages 513-518

  Shaarawy, M ^a   El Sharkawy, S A ^a  

^a Roxy Building ^*  (Egypt)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGRAPHY; BIOMARKERS; TUMORS;

POSTMENOPAUSAL;

ONCOLOGY;

BIOLOGICAL MARKER; ENDOSTATIN; VASCULOTROPIN;

ADULT; ADVANCED CANCER; AGED; ANGIOGENESIS; ARTICLE; CANCER STAGING; CONTROLLED STUDY; EARLY DIAGNOSIS; ENDOMETRIUM CANCER; ENDOMETRIUM HYPERPLASIA; FEMALE; HUMAN; MAJOR CLINICAL STUDY; METASTASIS; POSTMENOPAUSE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; RELAPSE; TUMOR GROWTH;

AGED; COLLAGEN; ENDOMETRIAL NEOPLASMS; ENDOMETRIUM; ENDOSTATINS; ENDOTHELIAL GROWTH FACTORS; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERPLASIA; HYSTERECTOMY; LYMPHOKINES; MIDDLE AGED; NEOPLASM METASTASIS; NEOPLASM PROTEINS; NEOPLASM STAGING; NEOVASCULARIZATION, PATHOLOGIC; OVARIECTOMY; PEPTIDE FRAGMENTS; POSTMENOPAUSE; PROGNOSIS; TREATMENT OUTCOME; TUMOR MARKERS, BIOLOGICAL; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0034914806     PISSN: 0284186X     EISSN: None     Source Type: Journal    
DOI: 10.1080/028418601750288253     Document Type: Article

References (26)

1. The epidemiology of endometrial cancer
2. Vascular physiology. A family of angiogenic peptides
3. Validation of anti-vascular endothelial growth factor antibodies for immunohistochemical localization of VEGF in tissue sections: Expression of VEGF in the human endometrium
4. Vascular endothelial growth factor expression in cycling human endometrium
5. Angiogenesis and tumor metastasis
6. Angiogenesis in endometrial carcinoma
7. Inhibition of VEGF-induced angiogenesis suppresses tumor growth in vivo
8. Serum levels of interleukins, growth factors and angiogenin in patients with endometrial cancer
9. Expression of VEGF and its receptors in endometrial carcinoma
10. Vascular endothelial growth factor messenger ribonucleic acid expression in human ovarian and endometrial cancer
11. The role of VEGF in pathological angiogenesis
12. Tumor angiogenesis, review of current application in tumor prognostication
13. Tumor interaction with the vasculature; angiogenesis and tumor metastasis
14. Vessel density in carcinoma of the prostate: Comparing organ confined tumors with stage D tumors
15. Relation of neovasculature to metastasis of non-small cell lung cancer
16. Tumour angiogenesis in stage IB cervical cancer: Correlation of micovessel density with survival
17. Assessment of tumor vascularity as a prognostic factor in lymph node negative invasive breast cancer
18. How tumors become angiogenic
19. The clinical value of detecting extracellular domain of c-erb B-2 oncoprotein and p53 tumor suppressor gene mutant protein in hyperplastic and malignant endometrium
20. Human angiostatin inhibits murine hemangioendothelioma tumor growth in vivo
21. Isolation and characterization of the circulating form of human endostatin
22. Tumor angiogenesis
23. The diagnostic and prognostic value of tumor angiogenesis
24. Endostatin: An endogenous inhibitor of angiogenesis and tumor growth
25. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis
26. Systemic inhibition of tumor growth and tumor metastasis by intramuscular administration of the endostatin gene